Purchases and Sales Made in Q2 2024 in Zentalis Pharmaceuticals, Inc. (ZNTL)
This table provides information about the institutional ownership of Zentalis Pharmaceuticals, Inc. (ZNTL) during Q2 2024. The information is specifically focused on institutions that hold shares of Zentalis Pharmaceuticals, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Jul 19, 2024
Q2 2024
|
China Universal Asset Management Co., Ltd.
Shanghai, F4 |
SELL
|
- |
-5.29K- 38.81% |
$21.6K - $85.3K
|
8.34K
$25K
|
|
Aug 14, 2024
Q2 2024
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
SELL
|
- |
-7.08K- 22.96% |
$28.9K - $114K
|
23.7K
$71.2K
|
|
Jul 29, 2024
Q2 2024
|
Zurcher Kantonalbank (Zurich Cantonalbank)
Zurich, V8 |
SELL
|
- |
-7.81K- 50.0% |
$31.9K - $126K
|
7.81K
$23.4K
|
|
Aug 14, 2024
Q2 2024
|
Engineers Gate Manager LP
New York, NY |
SELL
|
- |
-11K- 42.85% |
$44.9K - $177K
|
14.6K
$43.9K
|
|
Aug 13, 2024
Q2 2024
|
Profund Advisors LLC
|
SELL
|
- |
-15.5K- 33.43% |
$63.4K - $250K
|
30.9K
$92.7K
|
|
Aug 14, 2024
Q2 2024
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-19.1K- 32.15% |
$77.9K - $307K
|
40.2K
$121K
|
|
Aug 14, 2024
Q2 2024
|
Northern Trust Corp
Chicago, IL |
SELL
|
- |
-28.4K- 5.43% |
$116K - $459K
|
495K
$1.49M
|
|
Jul 30, 2024
Q2 2024
|
Mirae Asset Global Investments Co., Ltd.
|
SELL
|
- |
-29.5K- 93.29% |
$121K - $475K
|
2.12K
$6.36K
|
|
Dec 03, 2024
Q2 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-30.7K- 61.48% |
$126K - $495K
|
19.2K
$57.7K
|
|
Aug 14, 2024
Q2 2024
|
Bio Impact Capital LLC
Cambridge, MA |
SELL
|
- |
-66.2K- 4.37% |
$271K - $1.07M
|
1.45M
$4.35M
|
|
Aug 15, 2024
Q2 2024
|
Pdt Partners, LLC
New York, NY |
SELL
|
- |
-91K- 69.31% |
$372K - $1.47M
|
40.3K
$121K
|
|
Aug 09, 2024
Q2 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-97K- 13.4% |
$397K - $1.56M
|
627K
$1.88M
|
|
Aug 14, 2024
Q2 2024
|
Voya Investment Management LLC
Atlanta, GA |
SELL
|
- |
-125K- 86.69% |
$513K - $2.02M
|
19.2K
$57.7K
|
|
Aug 13, 2024
Q2 2024
|
Rafferty Asset Management, LLC
New York, NY |
SELL
|
- |
-130K- 43.77% |
$534K - $2.1M
|
168K
$503K
|
|
Aug 02, 2024
Q2 2024
|
Td Asset Management Inc
|
SELL
|
- |
-156K- 60.25% |
$638K - $2.52M
|
103K
$309K
|
|
Aug 13, 2024
Q2 2024
|
Ubs Group Ag
|
SELL
|
- |
-161K- 60.02% |
$658K - $2.59M
|
107K
$321K
|
|
Aug 12, 2024
Q2 2024
|
Citigroup Inc
|
SELL
|
- |
-213K- 82.91% |
$872K - $3.44M
|
43.9K
$132K
|
|
Aug 14, 2024
Q2 2024
|
Verition Fund Management LLC
Greenwich, CT |
SELL
|
- |
-602K- 52.15% |
$2.46M - $9.72M
|
553K
$1.66M
|
|
Aug 14, 2024
Q2 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-733K- 19.37% |
$3M - $11.8M
|
3.05M
$9.16M
|
|
Aug 08, 2024
Q2 2024
|
Federated Hermes, Inc.
Pittsburgh, PA |
SELL
|
- |
-1.52M- 75.86% |
$6.2M - $24.5M
|
482K
$1.45M
|
|
Aug 14, 2024
Q2 2024
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
SELL
|
- |
-1.99M- 60.06% |
$8.15M - $32.2M
|
1.33M
$3.98M
|
|
Aug 13, 2024
Q2 2024
|
Capital International Investors
Los Angeles, CA |
SELL
|
- |
-2.14M- 76.05% |
$8.77M - $34.6M
|
675K
$2.03M
|
|
Aug 14, 2024
Q2 2024
|
Price T Rowe Associates Inc
Baltimore, MD |
SELL
|
- |
-2.57M- 73.52% |
$10.5M - $41.4M
|
924K
$2.77M
|
|
Aug 13, 2024
Q2 2024
|
Eventide Asset Management, LLC
Boston, MA |
SELL
|
- |
-3.03M- 26.15% |
$12.4M - $48.8M
|
8.55M
$25.6M
|